Intrinsiqs

Is Gossamer Bio, Inc. overvalued?

Gossamer Bio, Inc. (GOSS) — key valuation metrics and fundamentals.

No verdict
Price
$10.94
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$66.8M
Dividend yield
0.0%
Return on equity
108.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GOSS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.